Pricing

Phyllis Fichera

No bio yet

Location

Boston, United States

Links

Previous companies

Org chart

No direct reports

This person is not in any offices

Urovant Sciences

Urovant Sciences, innovations in urology. Our lead therapeutic candidate is vibegron (RVT-901), an investigational oral β3-adrenergic agonist

Industries

Headquarters

Employees

Links